RISK OF AGE-RELATED MACULAR DEGENERATION IN END-STAGE RENAL DISEASE PATIENTS RECEIVING LONG-TERM DIALYSIS

Purpose: This study investigated the risk of age-related macular degeneration (AMD) in patients with end-stage renal disease (ESRD) receiving long-term dialysis and compared the risk between various dialysis modalities using propensity score-matching methods. Methods: From the National Health Insurance Research Database of Taiwan, the authors identified 27,232 patients with ESRD newly diagnosed from 2000 to 2010, including 9,287 patients on peritoneal dialysis (PD) and 17,945 patients on hemodialysis (HD). A total of 108,928 controls without kidney disease were randomly selected and frequency matched by age, sex, and index year of ESRD patients. The authors established an additional HD cohort matched by propensity scores of PD patients (N = 9,256 each). All cohorts were followed up until the end of 2011 to measure the incidence of AMD. Results: The incidences of AMD were 1.84, 4.03, 5.37, and 3.50 per 1,000 person-years in the control, ESRD (PD and HD), PD, and HD cohorts, respectively. The hazard ratios for AMD were 1.72, 2.47, and 1.43 for the ESRD, PD, and HD cohorts, with 95% confidence intervals of 1.50 to 1.97, 2.05 to 2.98, and 1.22 to 1.68, respectively, compared with the control cohort. The patients on PD exhibited a hazard ratio of 1.74 (95% confidence interval = 1.27–2.38) for developing AMD compared with propensity score-matched patients on HD. Conclusion: Patients with ESRD may exhibit a higher risk of AMD than people without kidney disease. Patients on PD may be more likely to develop AMD than patients on HD.

[1]  Tien Yin Wong,et al.  Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways. , 2014, Kidney international.

[2]  Gretchen A. Stevens,et al.  Causes of vision loss worldwide, 1990-2010: a systematic analysis. , 2013, The Lancet. Global health.

[3]  W. van Biesen,et al.  A multicentric, international matched pair analysis of body composition in peritoneal dialysis versus haemodialysis patients. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  P. Stenvinkel,et al.  Chronic kidney disease: a clinical model of premature aging. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  H. Tighiouart,et al.  Kidney function, albuminuria and age-related macular degeneration in NHANES III. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  B. Nan,et al.  Rates of nonexudative and exudative age-related macular degeneration among Asian American ethnic groups. , 2011, Investigative ophthalmology & visual science.

[7]  R. Klein,et al.  Serum cystatin C level, kidney disease markers, and incidence of age-related macular degeneration: the Beaver Dam Eye Study. , 2009, Archives of ophthalmology.

[8]  L. Smeeth,et al.  Associations Between Chronic Kidney Disease and Age-Related Macular Degeneration , 2009, Ophthalmic epidemiology.

[9]  Bin Wang,et al.  Smoking and the risk of age-related macular degeneration: a meta-analysis. , 2008, Annals of epidemiology.

[10]  P. Mitchell,et al.  CKD increases the risk of age-related macular degeneration. , 2008, Journal of the American Society of Nephrology : JASN.

[11]  I. Deary,et al.  Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.

[12]  J. Coombes,et al.  Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification , 2007, Nephrology.

[13]  B. Rosner,et al.  Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. , 2007, JAMA.

[14]  T. Sairenchi,et al.  Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. , 2007, Kidney international.

[15]  F. Dekker,et al.  Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey , 2006, BMJ : British Medical Journal.

[16]  J L McRae,et al.  Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease) , 2005, Journal of Medical Genetics.

[17]  John D Lambris,et al.  Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. , 2005, Journal of the American Society of Nephrology : JASN.

[18]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[19]  J. Morrow,et al.  Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. , 2004, Kidney international.

[20]  B. Rosner,et al.  Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. , 2003, Archives of ophthalmology.

[21]  H. Izzedine,et al.  Eye and kidney: from clinical findings to genetic explanations. , 2003, Journal of the American Society of Nephrology : JASN.

[22]  J. Haines,et al.  A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy , 2002, Ophthalmic genetics.

[23]  C. Zoccali,et al.  Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  E. Friedman,et al.  The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. , 2000, American journal of ophthalmology.

[25]  R. Klein,et al.  The Wisconsin age-related maculopathy grading system. , 1991, Ophthalmology.

[26]  A. Demaine,et al.  Evolution of IgA glomerulonephritis: relation to morphology, immunogenetics, and BP. , 1987, Seminars in nephrology.

[27]  A. Ramé [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.

[28]  P. Zipfel,et al.  Complement and diseases: defective alternative pathway control results in kidney and eye diseases. , 2006, Molecular immunology.

[29]  A. Hofman,et al.  Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. , 2003, Investigative ophthalmology & visual science.

[30]  J. Seddon,et al.  Do age-related macular degeneration and cardiovascular disease share common antecedents? , 1999, Ophthalmic epidemiology.